Company / Return on Equity (ROE)
Perspective Therapeutics, Inc. Return on Equity (ROE) History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-13.3%
FY2022
5-year range
-133.2% / -13.3%
FY2018-FY2022
Trend
+80.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Perspective Therapeutics, Inc. reports negative total equity of -13.3% in FY2022. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-13.3% in FY2022 with a 5-year CAGR of +4.4%.
Improved from -133.2% to -13.3% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +44.8pp
- 5-Year Change
- +4.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on equity (roe) increased 80.1% year-over-year.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -13.3% | +80.1% |
| FY2021 | -67.0% | +49.7% |
| FY2020 | -133.2% | -129.2% |
| FY2019 | -58.1% | -102.4% |
| FY2018 | -28.7% | -62.2% |
| FY2017 | -17.7% | +28.8% |
| FY2016 | -24.9% | +65.4% |
| FY2015 | -71.9% | -8.4% |
| FY2014 | -66.3% | -10.5% |
| FY2013 | -60.0% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026